Dr. Maher Albitar of Genomic Testing Cooperative is among the study’s co-authors.
Read the publication in Modern Pathology
DOI: 10.1016/j.modpat.2026.101054
Published online: August 13, 2026.
Dr. Maher Albitar of Genomic Testing Cooperative is among the study’s co-authors.
Read the publication in Modern Pathology
DOI: 10.1016/j.modpat.2026.101054
Published online: August 13, 2026.
New Paper published in FEBS openbio Cell-free RNA (cfRNA) is emerging as a supplemental approach for liquid biopsy (LBx). Given that lymphoid cells and plasma cells express substantial quantities of
Abstract Cancer classification traditionally focuses on tissue of origin and histology appearance. Traditional “hard” classification for a specific diagnostic class yields binary yes/no class prediction. However, newer therapeutic approaches have
A pilot feasibility study published in Blood Neoplasia demonstrates the potential of comprehensive cfDNA + cfRNA liquid biopsy for molecular profiling in cutaneous T-cell lymphoma (CTCL). Using GTC’s high-depth NGS platform, researchers achieved a 79% mutation
Get all the critical news and events sent straight to your inbox